Karin Lundberg Selected Research

acetyl 4-aminosalicylic acid

10/2020	Different Hierarchies of Anti-Modified Protein Autoantibody Reactivities in Rheumatoid Arthritis.
1/2019	A cross-sectional investigation into the association between Porphyromonas gingivalis and autoantibodies to citrullinated proteins in a German population.
1/2019	Generation and Characterization of Anti-Citrullinated Protein Antibody-Producing B Cell Clones From Rheumatoid Arthritis Patients.
4/2016	Identification of a novel chemokine-dependent molecular mechanism underlying rheumatoid arthritis-associated autoantibody-mediated bone loss.
3/2016	Antibodies to Porphyromonas gingivalis Indicate Interaction Between Oral Infection, Smoking, and Risk Genes in Rheumatoid Arthritis Etiology.
1/2016	Antibodies to carbamylated α-enolase epitopes in rheumatoid arthritis also bind citrullinated epitopes and are largely indistinct from anti-citrullinated protein antibodies.
8/2014	Affinity purified anti-citrullinated protein/peptide antibodies target antigens expressed in the rheumatoid joint.
5/2013	Genetic and environmental determinants for disease risk in subsets of rheumatoid arthritis defined by the anticitrullinated protein/peptide antibody fine specificity profile.
10/2012	Validation of a multiplex chip-based assay for the detection of autoantibodies against citrullinated peptides.
1/2010	Antibodies to several citrullinated antigens are enriched in the joints of rheumatoid arthritis patients.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Karin Lundberg Research Topics

Disease

48	Rheumatoid Arthritis 01/2023 - 09/2004
8	Periodontitis 02/2022 - 12/2010
8	Inflammation (Inflammations) 01/2019 - 01/2005
6	Arthritis (Polyarthritis) 11/2016 - 01/2005
3	Pain (Aches) 01/2022 - 06/2011
3	Multiple Sclerosis 01/2021 - 01/2008
3	Infections 11/2016 - 12/2010
2	Neoplasms (Cancer) 01/2018 - 09/2015
1	Myocardial Infarction 02/2022
1	Periodontal Diseases (Periodontal Disease) 01/2021
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 01/2021
1	Dermatomyositis (Dermatopolymyositis) 01/2018
1	Disease Progression 11/2016
1	Arthralgia (Joint Pain) 04/2016
1	Osteoarthritis 12/2015
1	Necrosis 12/2015
1	Psoriatic Arthritis 12/2015
1	Chronic Obstructive Pulmonary Disease (COPD) 01/2015
1	Metrorrhagia (Spotting) 10/2012
1	Joint Diseases (Joint Disease) 06/2011
1	Down Syndrome (Down's Syndrome) 05/2010
1	Autoimmune Diseases (Autoimmune Disease) 01/2010
1	Bacterial Infections (Bacterial Infection) 10/2008
1	Experimental Arthritis 01/2005

Drug/Important Bio-Agent (IBA)

30	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2005
25	AntibodiesIBA 02/2022 - 01/2005
17	Anti-Citrullinated Protein AntibodiesIBA 02/2022 - 01/2010
16	Peptides (Polypeptides)IBA 01/2018 - 01/2008
13	AutoantibodiesIBA 01/2023 - 01/2005
10	acetyl 4-aminosalicylic acidIBA 10/2020 - 01/2010
9	Phosphopyruvate Hydratase (Enolase)IBA 01/2016 - 01/2005
8	EpitopesIBA 01/2022 - 01/2006
8	AutoantigensIBA 02/2016 - 01/2005
7	Immunoglobulin G (IgG)IBA 02/2022 - 01/2014
7	AntigensIBA 01/2018 - 01/2005
6	HLA-DRB1 Chains (HLA DRB1)IBA 01/2022 - 12/2009
5	Protein-Arginine DeiminasesIBA 01/2018 - 09/2010
5	EnzymesIBA 01/2018 - 01/2005
5	Fibrinogen (Factor I)FDA Link 06/2015 - 01/2010
4	CitrullineIBA 01/2015 - 01/2005
4	Collagen Type II (Type II Collagen)IBA 05/2013 - 09/2004
3	Gingipain Cysteine EndopeptidasesIBA 02/2022 - 03/2016
3	Rheumatoid FactorIBA 01/2021 - 01/2020
3	C-Reactive ProteinIBA 09/2017 - 06/2011
2	Virulence Factors (Pathogenicity Factors)IBA 02/2022 - 03/2016
2	Biomarkers (Surrogate Marker)IBA 02/2022 - 01/2018
2	cyclic citrullinated peptideIBA 01/2021 - 01/2020
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 12/2015
2	ImmunosorbentsIBA 01/2018 - 03/2016
2	ChemokinesIBA 04/2016 - 04/2016
2	Arginine (L-Arginine)FDA Link 12/2015 - 01/2008
2	VimentinIBA 01/2015 - 05/2013
1	anti-dsDNA autoantibodyIBA 02/2022
1	Immunoglobulin A (IgA)IBA 01/2021
1	HLA-B Antigens (HLA-B)IBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2020
1	Epstein-Barr Virus Nuclear AntigensIBA 01/2019
1	AnoctaminsIBA 01/2019
1	Messenger RNA (mRNA)IBA 01/2018
1	Glycoproteins (Glycoprotein)IBA 11/2016
1	pristane (pristan)IBA 11/2016
1	CytokinesIBA 11/2016
1	TenascinIBA 10/2016
1	Extracellular Matrix ProteinsIBA 10/2016
1	reparixinIBA 04/2016
1	Methotrexate (Mexate)FDA LinkGeneric 09/2015
1	homocitrullineIBA 01/2015
1	Bovine Serum AlbuminIBA 10/2014
1	Polysaccharides (Glycans)IBA 01/2014
1	BuffersIBA 10/2012
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 05/2012
1	Antigen-Antibody Complex (Immune Complex)IBA 01/2010
1	HLA-DR Antigens (HLA-DR)IBA 01/2006
1	Serum AlbuminIBA 01/2005
1	serum P-component (CIt)IBA 01/2005

Therapy/Procedure

1	Ligation 11/2016
1	Therapeutics 09/2015